trending Market Intelligence /marketintelligence/en/news-insights/trending/lysahrmyaovya17xgcvcra2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cancer Genetics chief medical officer leaves to pursue other research interests

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Cancer Genetics chief medical officer leaves to pursue other research interests

Cancer Genetics Inc. said Rita Shaknovich will resign as chief medical officer and group medical director effective Sept. 12.

The Rutherford, N.J.-based company believes its existing staff will be able to manage ongoing operations and is exploring internal promotions to ensure a smooth transition of Shaknovich's responsibilities.

Shaknovich plans to pursue other interests related to oncology research, the company said in an Aug. 10 regulatory filing.